Crossmark

Antithymocyte globulin administration in patients with profound lymphopenia receiving a PBSC purine analog/busulfan-based conditioning regimen allograft

Crossref DOI link: https://doi.org/10.1038/s41598-020-72415-7

Published Online: 2020-09-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jullien, Maxime

Guillaume, Thierry

Peterlin, Pierre

Garnier, Alice

Le Bourgeois, Amandine

Debord, Camille

Mahe, Beatrice

Dubruille, Viviane

Wuilleme, Soraya

Blin, Nicolas

Touzeau, Cyrille

Gastinne, Thomas

Tessoulin, Benoit

Le Bris, Yannick

Eveillard, Marion

Duquesne, Alix

Moreau, Philippe

Le Gouill, Steven

Bene, Marie C.

Chevallier, Patrice
License Information

Text and Data Mining valid from 2020-09-21

Version of Record valid from 2020-09-21
More Information

Article History

Received: 17 March 2020

Accepted: 1 September 2020

First Online: 21 September 2020

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below